Rezolve AI has cleared its August 6 earnings hurdle with the short thesis at its most aggressive in months — yet the stock closed the week up 8.9%, leaving bears in an uncomfortable spot.
The positioning picture is unambiguous on one side: short sellers are more dug in than at any point in the recent cycle. Short interest has climbed to 14.6% of free float — 43.8 million shares — up 14.8% on the week alone. That is the highest level in the 30-day history shown, and the ORTEX short score has risen every session this week to reach 80.5, a ranking in approximately the first percentile of the broader universe. Bears have added roughly 5.6 million shares since last Thursday, continuing the relentless rebuild that began from the mid-July trough near 25.8 million shares. The borrow market has tightened in lockstep. Cost to borrow has jumped from around 16% APR a week ago to 60% APR — a 278% move in seven sessions — echoing the dynamic seen in late June when CTB briefly touched 211% before collapsing. Availability has slipped further to 20.9%, meaning roughly one share remains for every four already lent out. That is the tightest the lending pool has been since early July, and it raises the friction cost for any new short entry meaningfully. The ORTEX short score ranking of first percentile confirms this is one of the most heavily pressed names in the application software universe right now.
Options traders are not getting the memo. The put/call ratio has actually declined this week to 0.25, sitting below its 20-day average of 0.26 and near the 52-week low of 0.11 — call volume continues to dominate. This is the same divergence noted in prior weeks: while short sellers added aggressively into and through the earnings print, options positioning has remained tilted toward upside. That contradiction has not resolved; it has simply persisted through the catalyst. Post-earnings, the stock's 8.9% weekly gain and Thursday's 2.5% close at $2.44 give options bulls the short-term result they were positioning for, while shorts now carry a larger unrealised loss.
The fundamental backdrop does little to settle the debate. Rezolve's growth pillar remains exceptional by scoring standards, but quality and value metrics are deeply negative — return on assets, EV/EBIT, and P/E are all in loss-making territory. The institutional register is heavily concentrated: the top two holders, Dblp Sea Cow Limited and Igor Lychagov, account for roughly 21% of shares between them, and Alejandro Gonzalez added 7.25 million shares as recently as July 14, bringing his stake to 7.5% of the company. The CEO and founder Daniel Wagner also bought $3.25 million worth of stock in April at $4.00 — a price well above the current $2.44. Those insider purchases now sit underwater, which adds a layer of complexity to any near-term supply-demand calculus. Peer context offers little comfort: AISP fell 12.9% on the week and GRRR dropped 7.7%, while PLTR and BLND closed roughly flat to modestly higher — RZLV's 8.9% gain looks like an outlier, not a sector move.
The next focal point is how quickly — or whether — the borrow market re-tightens from its current 60% APR level toward the late-June peak above 200%, and whether the 14.6% short interest figure continues its ascent or stabilises now that the earnings catalyst has passed.
See the live data behind this article on ORTEX.
Open RZLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
